AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Sanofi-Aventis (France) remodels R&D, eight sites close, no forced layoffs.

Chemical Business Newsbase

| June 30, 2009 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Sanofi-aventis presented its new Research and Development model project. The model, which aims to transform R&D and increase innovation, is the first pillar of the Group's new strategy which was presented in Feb 2009 by Christopher A Viehbacher, Chief Executive Officer of sanofi-aventis. The rapid evolution of the scientific environment, which is bringing about a veritable revolution in biopharmaceutical research, namely in biology, has generated a profound and continuous change in the pharmaceutical environment. To anticipate the consequences of this mutation and to maintain its innovative capacities, sanofi-aventis intends to set in place the most effective R&D organization in …

Related articles from newspapers, magazines, journals, and more
France's Aventis braced for #35 bn hostile bid from Sanofi.
News wire article from: Asia Africa Intelligence Wire January 26, 2004 700+ words
MOVERS AND SHAKERS: GLENMARK PHARMA OUTLICENSES GBR 500 TO SANOFI OF FRANCE...
Magazine article from: India Business Insight August 7, 2011 700+ words
GLENMARK SELLS DRUG RIGHTS (to Sanofi of France to develop and market a...
Magazine article from: India Business Insight June 12, 2011 700+ words
SANOFI ACQUIRES SHANTHA BIOTECHNICS (from Merieux Alliance of France).
Magazine article from: India Business Insight August 3, 2009 700+ words
NovaMed Ltd and Sanofi-Aventis (France) extend collaboration in China.
News wire article from: Chemical Business Newsbase July 28, 2008 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily